Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1
- PMID: 37949089
- DOI: 10.1016/S1473-3099(23)00682-5
Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1
Conflict of interest statement
This work was supported by co-funding from the EU's EU4Health programme (grant agreement number 101102733 DURABLE). Views and opinions expressed do not necessarily reflect those of the EU or European Health and Digital Executive Agency. Neither the EU nor the granting authority can be held responsible for them. The funder did not have any role in writing of the Correspondence or the decision to submit it for publication. LN serves as a council member of the European Society of Clinical Virology and is head of the Danish Society for Clinical Microbiology virology working group. PJ is the science officer of the European Society of Clinical Microbiology and Infectious Diseases Study Group in Public Health Microbiology, and a member of the European Society of Clinical Microbiology and Infectious Diseases Emerging Infections Task Force. All other authors declare no competing interests.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous